(Q48316037)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29131530%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

title

Biomarkers for immune checkpoint inhibitors: The importance of tumor topography and the challenges to cytopathology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29131530%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29131530%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

author name string

Douglas P Clark

series ordinal

1

1 reference

10 February 2018

http://europepmc.org/abstract/MED/29131530

language of work or name

English

0 references

publication date

13 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29131530%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29131530%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

volume

126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29131530%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29131530%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

11-19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29131530%20AND%20SRC:MED&resulttype=core&format=json

Programmed Death Ligand-1 (PD-L1) Expression in the Programmed Death Receptor-1 (PD-1)/PD-L1 Blockade: A Key Player Against Various Cancers

2 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

The blockade of immune checkpoints in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

Elements of cancer immunity and the cancer-immune set point

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

PD-1 blockade induces responses by inhibiting adaptive immune resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

Oncology meets immunology: the cancer-immunity cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

A Quantitative Comparison of Antibodies to Programmed Cell Death 1 Ligand 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

Agreement between Programmed Cell Death Ligand-1 Diagnostic Assays across Multiple Protein Expression Cutoffs in Non-Small Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

Improvement of cellularity on cell block preparations using the so-called tissue coagulum clot method during endobronchial ultrasound-guided transbronchial fine-needle aspiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

Mutational heterogeneity in cancer and the search for new cancer-associated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

Genetic basis for clinical response to CTLA-4 blockade in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21951

21 January 2018

Identifiers

DOI

10.1002/CNCY.21951

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29131530%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference